Opera Limited Sponsored ADR (OPRA) closed the last trading session at $15.09, gaining 14.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

H.C. Wainwright notes that Roche’s (RHHBY) persevERA trial “disappointingly” failed, though the firm does not view the frontline opportunity as eliminated for palazestrant and does not believe the ...